About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New 'Synthetic Polio Vaccine' in the Pipeline

by Dr. Trupti Shirole on February 16, 2015 at 10:08 AM
Font : A-A+

 New 'Synthetic Polio Vaccine' in the Pipeline

Scientists from the US and UK hope to create a wholly artificial safe vaccine to combat polio by copying the viral genome. The scientists hope by artificially replicating the virus, in effect removing its genetic machinery, they can avoid using a weakened version of the polio virus in the oral polio vaccine used currently.

Researcher Dave Stuart said, "The idea of the synthetic vaccine is that it contains no genome as it's virus free and so it's made, in a way, like a super-chemical, a complicated chemical, that assembles itself to look like the virus but has no way of ever replicating. Early results with polio vaccine are very promising, with synthetic particles being produced and evidence of successful stabilization."

Advertisement

In rare cases the oral medication provokes a reaction in the patient's gut which allows a reactivated virus to pass out of the body and spread to other unvaccinated individuals.

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Drug News

Is Fomepizole the Key to Overcoming Antibiotic-Resistant Pneumonia?
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
 Combination Therapy Benefits Septic Shock Patients
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New 'Synthetic Polio Vaccine' in the Pipeline Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests